ArticleBMJ paediatrics open2026
Neurodevelopmental outcomes of children born to diabetic mothers in the Qatari population: a retrospective study.
Article in BMJ paediatrics open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMaternal diabetes is linked to adverse perinatal outcomes, but its association with neurodevelopmental delays in offspring remains unclear. This study aimed to investigate the relationship between maternal diabetes and neurodevelopmental outcomes in children born to Qatari mothers.
methodsThis retrospective population-based cohort study included full-term children born in 2017 to Qatari mothers with gestational diabetes, pre-pregnancy diabetes, or no diabetes. Neurodevelopmental outcomes such as autism spectrum disorder (ASD), speech delay, and gross and fine motor delays were assessed at the age of 4 years. Data for the study were retrieved from electronic medical records.
resultsOf the 5141 eligible children, 1222 (23.8%) were born to mothers with gestational diabetes mellitus (GDM), 140 (2.7%) to mothers with pre-pregnancy diabetes and 3779 (73.5%) to non-diabetic mothers. Overall, 70 (1.58%) children were diagnosed with autism, 161 (3.63%) with speech delay, 44 (0.99%) with gross motor delay and 43 (0.97%) with fine motor delay. In crude analyses, children of mothers with GDM had significantly higher odds of autism (OR 1.70, 95% CI 1.03 to 2.81) and speech delay (OR 1.44, 95% CI 1.02 to 2.04) compared with controls. However, these associations were not statistically significant after adjusting for confounders (autism: adjusted odds ratio (aOR) 1.58, 95% CI 0.94 to 2.66; speech delay: adjusted odds ratio (aOR) 1.39, 95% CI 0.97 to 2.00). No significant associations were observed between maternal diabetes and gross or fine motor delays in either crude or adjusted models.
conclusionDespite non-significant associations, findings highlight the role of effective diabetes management and the need for region-specific, longitudinal research on child neurodevelopment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.